Literature DB >> 1316934

Transition from interleukin 1 beta (IL-1 beta) to IL-1 alpha production during maturation of inflammatory macrophages in vivo.

H U Beuscher1, U P Rausch, I G Otterness, M Röllinghoff.   

Abstract

In situ production of interleukin 1 alpha (IL-1 alpha) and IL-1 beta was investigated in Peyer's patches (PP) of mice undergoing an acute bacterial infection with Yersinia enterocolitica O8. Synthesis of IL-1 beta, as determined by immunohistochemistry, was found primarily in monocytes migrating into the inflamed PP. In comparison, synthesis of IL-1 alpha was temporarily delayed by at least 24 h and was only found in mature macrophages, which did not produce detectable levels of IL-1 beta. This indicates a transition from IL-1 beta to IL-1 alpha production during maturation of monocytes into inflammatory macrophages, and further emphasizes a dichotomy between IL-1 alpha and IL-1 beta.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1316934      PMCID: PMC2119227          DOI: 10.1084/jem.175.6.1793

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  12 in total

Review 1.  The proinflammatory cytokines interleukin-1 and tumor necrosis factor and treatment of the septic shock syndrome.

Authors:  C A Dinarello
Journal:  J Infect Dis       Date:  1991-06       Impact factor: 5.226

2.  Differential activity of interleukin 1 alpha and interleukin 1 beta in the stimulation of the immune response in vivo.

Authors:  D Boraschi; L Villa; G Volpini; P Bossù; S Censini; P Ghiara; G Scapigliat; L Nencioni; M Bartalini; G Matteucci
Journal:  Eur J Immunol       Date:  1990-02       Impact factor: 5.532

3.  IL-1 beta is secreted by activated murine macrophages as biologically inactive precursor.

Authors:  H U Beuscher; C Günther; M Röllinghoff
Journal:  J Immunol       Date:  1990-03-15       Impact factor: 5.422

4.  The effects of differentiating agents on IL-1 beta production in cultured human monocytes.

Authors:  R W Janson; F G Joslin; W P Arend
Journal:  J Immunol       Date:  1990-10-01       Impact factor: 5.422

5.  Mac-1: a macrophage differentiation antigen identified by monoclonal antibody.

Authors:  T Springer; G Galfré; D S Secher; C Milstein
Journal:  Eur J Immunol       Date:  1979-04       Impact factor: 5.532

6.  Regulation of expression of human IL-1 alpha and IL-1 beta genes.

Authors:  M Turner; D Chantry; G Buchan; K Barrett; M Feldmann
Journal:  J Immunol       Date:  1989-12-01       Impact factor: 5.422

7.  Two interleukin 1 genes in the mouse: cloning and expression of the cDNA for murine interleukin 1 beta.

Authors:  P W Gray; D Glaister; E Chen; D V Goeddel; D Pennica
Journal:  J Immunol       Date:  1986-12-01       Impact factor: 5.422

Review 8.  Interleukin-1 and interleukin-1 antagonism.

Authors:  C A Dinarello
Journal:  Blood       Date:  1991-04-15       Impact factor: 22.113

9.  Human pro-IL-1 beta gene expression in monocytic cells is regulated by two distinct pathways.

Authors:  M J Fenton; M W Vermeulen; B D Clark; A C Webb; P E Auron
Journal:  J Immunol       Date:  1988-04-01       Impact factor: 5.422

10.  The cell surface receptors for interleukin-1 alpha and interleukin-1 beta are identical.

Authors:  S K Dower; S R Kronheim; T P Hopp; M Cantrell; M Deeley; S Gillis; C S Henney; D L Urdal
Journal:  Nature       Date:  1986 Nov 20-26       Impact factor: 49.962

View more
  14 in total

1.  Interleukin-34 induces monocytic-like differentiation in leukemia cell lines.

Authors:  Burthia E Booker; Ryan S Clark; Samuel T Pellom; Samuel E Adunyah
Journal:  Int J Biochem Mol Biol       Date:  2015-03-20

2.  Yersinia enterocolitica-induced interleukin-8 secretion by human intestinal epithelial cells depends on cell differentiation.

Authors:  R Schulte; I B Autenrieth
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

3.  Increased incidence of neutralizing autoantibodies against interleukin-1 alpha (IL-1 alpha) in nondestructive chronic polyarthritis.

Authors:  P Jouvenne; F Fossiez; P Garrone; O Djossou; J Banchereau; P Miossec
Journal:  J Clin Immunol       Date:  1996-09       Impact factor: 8.317

4.  Heterogeneity of Kupffer cells and splenic, alveolar, and peritoneal macrophages for the production of TNF, IL-1, and IL-6.

Authors:  C K Ogle; J Z Wu; X Mao; K Szczur; J W Alexander; J D Ogle
Journal:  Inflammation       Date:  1994-10       Impact factor: 4.092

5.  Transforming growth factor beta and CD25 are important for controlling systemic dissemination following Yersinia enterocolitica infection of the gut.

Authors:  Youmin Zhong; Angelene Cantwell; Peter H Dube
Journal:  Infect Immun       Date:  2010-06-28       Impact factor: 3.441

6.  A role for IL-1 alpha in inducing pathologic inflammation during bacterial infection.

Authors:  P H Dube; P A Revell; D D Chaplin; R G Lorenz; V L Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

7.  Endotoxin and interferon-gamma differentially regulate the transcriptional levels of proto-oncogenes and cytokine genes during the differentiation of colony-stimulating factor type-1-derived macrophages.

Authors:  M J Myers; N Ghildyal; L B Schook
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

8.  Environmental factors and not genotype influence the plasma level of interleukin-1 receptor antagonist in normal individuals.

Authors:  H Cullup; P G Middleton; G Duggan; J S Conn; A M Dickinson
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

9.  Different subsets of T cells in conjunction with natural killer cells, macrophages, and activated microglia participate in the intracerebral immune response to Toxoplasma gondii in athymic nude and immunocompetent rats.

Authors:  D Schlüter; A Hein; R Dörries; M Deckert-Schlüter
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

10.  Bacterial evasion of host immune defense: Yersinia enterocolitica encodes a suppressor for tumor necrosis factor alpha expression.

Authors:  H U Beuscher; F Rödel; A Forsberg; M Röllinghoff
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.